The optic nerve and retina are among the most metabolically demanding tissues in the body. They consume oxygen at a rate higher than almost any other tissue per unit weight, and they are supplied by a vascular network that is highly sensitive to both hypoxia and blood pressure dysregulation. Both of those stresses are delivered in large amounts by untreated sleep apnoea. The evidence linking OSA to multiple eye conditions — some of them capable of causing sudden, permanent vision loss — reflects this vulnerability.
Glaucoma
Glaucoma is the most common cause of irreversible blindness worldwide. It results from progressive damage to the optic nerve, most commonly associated with elevated intraocular pressure (pressure inside the eye), although a substantial proportion of cases occur at normal pressures. The damage accumulates silently over years, and by the time it is detected, significant vision has often already been lost.
A meta-analysis of 18 studies covering 1.7 million participants found that OSA patients have a 50 to 96 per cent higher risk of glaucoma compared with those without OSA — an odds ratio ranging from 1.50 to 1.96 across different study designs and populations. To translate the upper end of that range into real-world terms: glaucoma affects roughly 1 in 50 adults over 40 in the UK. With severe OSA, the evidence suggests that rises to roughly 1 in 25 — essentially doubling the baseline risk.
The mechanism is twofold. First, the repeated nocturnal oxygen drops from OSA cause direct hypoxic injury to the optic nerve head — the point where the nerve exits the eye and is most sensitive to ischaemia (oxygen deprivation). Second, the repeated overnight blood pressure swings from OSA dysregulate optic nerve blood flow, alternating between periods of underperfusion during hypotension and overperfusion during the hypertensive surges that follow each apnoea arousal. This haemodynamic instability — rather than simply elevated intraocular pressure — is thought to be the primary mechanism driving the OSA-glaucoma link.
OSA patients face between 50 and 96 per cent higher risk of glaucoma compared with those without the condition. Glaucoma is irreversible once damage occurs, which makes the prevention opportunity here clinically important.
Nonarteritic Anterior Ischaemic Optic Neuropathy (NAION): A Stroke of the Optic Nerve
NAION is a condition where the blood supply to the front section of the optic nerve is suddenly interrupted, causing acute, often permanent, vision loss in the affected eye. It is sometimes called a stroke of the optic nerve, and that is not an inaccurate description: the mechanism is vascular occlusion of the small arteries supplying the optic nerve head.
A meta-analysis found that OSA patients are nearly four times as likely to develop NAION compared with those without OSA — an odds ratio of 3.98. This is one of the largest risk elevations in the entire OSA literature for any specific condition. To put it in absolute terms: NAION is rare, affecting roughly 2 to 10 per 100,000 people per year. With severe OSA, the annual risk rises to roughly 8 to 40 per 100,000. These are still small absolute numbers, but the relative risk elevation of nearly four-fold is striking.
The proposed mechanism is that OSA-driven nocturnal hypotension (the blood pressure drops that follow each apnoea event in some patients) combined with nocturnal hypoxia creates the conditions for vascular occlusion specifically in the optic nerve disc, which is anatomically vulnerable due to its limited blood supply redundancy. NAION typically occurs on waking or shortly after, consistent with an overnight mechanism — a timing pattern that was noted clinically long before the OSA connection was established. The fact that NAION characteristically presents in the morning is itself a clinical clue that should prompt sleep apnoea screening in anyone presenting with this condition.
Retinal Vein Occlusion
Retinal vein occlusion (RVO) is a blockage of the veins draining blood from the retina — the light-sensitive tissue at the back of the eye. It causes blurring, distortion, or sudden vision loss depending on which vein is blocked and how completely. It is the second most common retinal vascular disorder after diabetic retinopathy.
A meta-analysis found that OSA patients are 2.71 times more likely to develop retinal vein occlusion compared with those without OSA. The mechanism involves the same factors driving NAION: elevated blood viscosity (thicker blood due to the polycythaemia — higher red blood cell count — that the body produces in response to chronic hypoxia), endothelial dysfunction impairing venous tone, and the haemodynamic fluctuations of repeated apnoea-arousal cycles creating conditions for venous stasis (slowing or pooling of blood) in the retinal venous system. Higher red cell count raises the risk of blood clotting in the slow-flow venous side of the circulation, and the retinal veins are particularly vulnerable.
Central Serous Chorioretinopathy
Central serous chorioretinopathy (CSC) is a condition where fluid accumulates under the retina, causing blurred or distorted central vision. It is associated with elevated cortisol and stress, which fits mechanistically with OSA given the chronic cortisol elevation that repeated overnight arousal responses produce. Studies have found higher rates of CSC in OSA patients, and the condition is more common in people with the sleep disruption, cortisol-dominated physiological profile that severe OSA creates.
Diabetic Eye Disease
For people with both diabetes and sleep apnoea — a common combination — OSA significantly worsens the retinal consequences of diabetes. Studies show that OSA in diabetic patients is associated with more severe diabetic retinopathy and faster progression of retinal damage compared with diabetic patients without OSA. The mechanism is additive: diabetes damages retinal vasculature through hyperglycaemia, and OSA adds hypoxic and inflammatory injury on top of that. The result is faster progression to vision-threatening retinopathy.
Floppy Eyelid Syndrome
This is a condition specifically and strongly associated with OSA in which the upper eyelid becomes soft, rubbery, and easily everts (turns inside out) when mechanical pressure is applied — for example, by sleeping face-down on a pillow. It causes chronic papillary conjunctivitis (redness and irritation of the inner eyelid surface) and sometimes corneal damage from exposure and mechanical abrasion. The exact mechanism linking floppy eyelid syndrome to OSA is debated, but elastin degradation in the eyelid tissue from OSA-associated oxidative stress is one proposed pathway. The clinical association is strong enough that floppy eyelid syndrome is now considered a marker that should prompt OSA screening.
What This Means in Practice
The practical message from this body of evidence is that OSA patients should be informed of their elevated eye disease risk and should have regular optometric and ophthalmological review. Conversely, optometrists and ophthalmologists seeing patients with glaucoma, NAION, retinal vein occlusion, or floppy eyelid syndrome should be asking about snoring and sleep quality, and referring appropriately for sleep assessment.
The vision consequences of conditions like NAION and advanced glaucoma are irreversible. Prevention through identifying and treating the underlying OSA earlier is the only realistic strategy for reducing the visual burden of these conditions in people who have untreated sleep apnoea.
References
[1] Shi Y et al. Obstructive sleep apnea and risk of glaucoma: a systematic review and meta-analysis. Eye. 2018. 18 studies, 1.7 million participants; pooled OR 1.96 for glaucoma in OSA patients; OR 1.50 in sensitivity analysis excluding lowest quality studies; dose-response relationship with OSA severity.
[2] Tsang CSL et al. Obstructive sleep apnea as a risk factor for non-arteritic anterior ischemic optic neuropathy: a meta-analysis of observational studies. Eye. 2019. Meta-analysis; OR 3.98 for NAION in OSA patients; consistent across study designs and populations.
[3] Zhao Q et al. Association between obstructive sleep apnea and retinal vein occlusion: a systematic review and meta-analysis. Current Eye Research. 2021. Meta-analysis; OR 2.71 for retinal vein occlusion in OSA patients.
[4] Abdal H et al. Floppy eyelid syndrome and obstructive sleep apnea: a systematic review. Journal of Ophthalmology. 2015. Systematic review; strong clinical association between floppy eyelid syndrome and OSA; elastin degradation proposed mechanism.
[5] Wang W et al. Obstructive sleep apnea and diabetic retinopathy: association and mechanisms. Current Diabetes Reports. 2022. Review; OSA in diabetic patients associated with significantly more severe retinopathy and faster progression; additive hypoxic and inflammatory injury proposed.
Contact Professor Vik Veer
If you would like to discuss a sleep assessment or arrange a consultation, please use the details below.
Private secretary: 0207 458 4584